Patent · US Active

Use of mitochondria-targeted electron scavengers as anti-inflammatory agents

US8487079B2 · kind B2 · utility

2Cited by

7References

26Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Mitchell P. Fink · Pittsburgh, US
Peter Wipf · Pittsburgh, US

Key dates

Filing date	Aug 8, 2008
Grant date	Jul 16, 2013
Priority date	—
Expiry date	Feb 15, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods for using mitochondria-targeted electron scavengers as anti-inflammatory agents. The mitochondria-targeted electron scavenger comprises a free radical-scavenging group covalently linked to a mitochondria-targeting group derived from a hemigramicidin moiety. The mitochondria-targeted electron scavenger can be used to treat medical conditions associated with acute or chronic inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.